UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PFE — Pfizer Inc
CIK 861177
NEW YORK, NY
Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$870,667,923
-$98,736,002 QoQ
Shares Held
36,157,306
+4.7% QoQ
Ownership
0.634%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#18
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $25,598,342,767 across 16 Drug Manufacturers - General names. PFE ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,209,385 | $8,647,153,365 | |
| 2 | JNJ |
Johnson & Johnson
|
18,416,123 | $4,677,142,752 | |
| 3 | ABBV |
AbbVie Inc.
|
14,267,697 | $3,590,323,267 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,547,171 | $2,511,811,470 | |
| 5 | AMGN |
Amgen Inc
|
5,390,910 | $1,952,156,323 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
12,986,591 | $1,640,725,902 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,839,010 | $1,315,983,749 | |
| 8 | PFE |
Pfizer Inc
This page
|
36,157,306 | $870,667,923 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $870,667,923 | 36,157,306 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $969,403,925 | 34,522,932 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $889,254,568 | 35,713,035 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $871,300,927 | 34,195,484 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,063,595,199 | 43,877,690 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $980,422,129 | 38,690,692 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,045,351,477 | 39,402,619 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,101,713,352 | 38,068,879 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $869,934,343 | 31,091,292 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $689,813,130 | 24,858,131 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $740,589,836 | 25,723,857 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $885,390,684 | 26,692,514 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $912,426,402 | 24,875,311 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,014,912,685 | 24,875,311 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,434,376,277 | 27,993,292 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,087,240,125 | 24,845,524 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,362,108,901 | 25,979,571 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,250,736,067 | 24,159,476 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,434,883,581 | 24,299,468 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,020,575,725 | 23,728,801 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $911,303,633 | 23,271,288 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $791,213,633 | 21,838,632 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $766,786,198 | 20,830,921 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $754,462,988 | 20,557,595 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $745,555,205 | 22,799,830 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $755,530,630 | 23,147,416 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||